ANSMフランス供給不足情報(2025年10月13日~10月19日)

Active ingredientsStatutUpdateSpecialty
digoxineSupply tension10/17/2025Digoxine Nativelle 5 µg/0.1 ml, solution buvable en gouttes
pyrantel (embonate of)Supply tension10/17/2025Combantrin 125 mg, tablet
rifamycin sodiumSupply tension10/17/2025Rifamycin Chibret 1000 000 IU per cent, eye drops solution
risperidoneSupply tension10/17/2025Risperidone 0.5 mg, 1 mg, 2 mg and 3 mg orodispersible tablet
risperidoneOut of stock10/17/2025Risperidone 4 mg Orodispersible tablet
olipudase alfaSupply tension15/10/2025Xenpozyme 20 mg, powder for solution to be diluted for infusion
pertuzumab/trastuzumabOut of stock15/10/2025Phesgo 1200 mg/600 mg, solution injectable
risperidoneOut of stock15/10/2025RisperdalConsta L.P. 37.5 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
risperidoneSupply tension15/10/2025RisperdalConsta L.P. 50 mg/2 ml and 25 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
risperidoneOut of stock15/10/2025Risperidone L.P. 25 mg/2 ml, 37.5 mg/2 ml and 50 mg/2 ml, powder and solvent for prolongedrelease suspension for injection in prefilled syringe
lenalidomideOut of stock15/10/2025Lenalidomide Mylan, capsule
dipyridamoleSupply tension15/10/2025Persantine 10 mg/2 mL, solution injectable, ampoule
chlorpromazine (hydrochloride)Supply tension13/10/2025Largactil 25 mg, filmcoated tablet
VaricellaZoster Virus (VZV) glycoprotein E antigen (recombinant, adjuvanted) (mammalian/hamster/CHO cells)Supply tension13/10/2025Shingrix, powder and suspension for injectable suspension. Varicella zoster vaccine (recombinant, adjuvanted)
esketamine (hydrochloride)Return to availability13/10/2025Eskesia 5 mg/mL, solution for injection/infusion  10 glass ampoule(s) of 5 ml
2025年10月20日
このページの先頭へ戻る